Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01262040 · ClinicalTrials.gov registry record · NA
Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 154
- Enrollment target
NCT01262040: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01262040 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 154 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01262040, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether narrowband imaging (NBI) makes it easier for a surgeon to see cancer. NBI is a kind of light. Normally, white light is used during surgery. White light uses many wavelengths of light. NBI only uses two wavelengths which highlight the blood vessels. This makes it easier for the surgeon to see blood vessels. Tumors often have more blood vessels than normal tissue. As a result, NBI may make it easier for the surgeon to see small tumors. In this study the surgeon will look with both normal white light and NBI. This way a comparison can be made to determine which is superior. Improved identification of tumors allows doctors and patients to make informed decisions about whether treatment is needed after surgery. It also provides additional information to determine which treatments may be best.
Interventions
- OTHER Narrow Band Imaging (NBI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2010-12-14 |
| Est. Completion | 2018-10-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01262040
The ClinicalTrials.gov registry entry for NCT01262040 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Narrow Band Imaging (NBI) is the first listed.
NCT01262040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01262040 about?
NCT01262040 is a clinical study titled "Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive". The purpose of this study is to determine whether narrowband imaging (NBI) makes it easier for a surgeon to see cancer. NBI is a kind of light. Normally, white light is used during surgery. White light uses many wavelengths of light. NBI only uses two wavelengths which highlight the blood vessels. ...
What is the current status of trial NCT01262040?
This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2010-12-14. Estimated completion is 2018-10-29.
What interventions are being tested in trial NCT01262040?
The interventions under investigation include: Narrow Band Imaging (NBI) (OTHER).
Who is sponsoring clinical trial NCT01262040?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.